The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
出版年份 2012 全文链接
标题
The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
作者
关键词
-
出版物
CARCINOGENESIS
Volume 34, Issue 1, Pages 199-210
出版商
Oxford University Press (OUP)
发表日期
2012-10-07
DOI
10.1093/carcin/bgs319
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
- (2012) K. Tran et al. Cancer Prevention Research
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
- (2011) C. DeSantis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin
- (2011) Michael A. Pereira et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor microenvironment and progression
- (2011) Harold F. Dvorak et al. JOURNAL OF SURGICAL ONCOLOGY
- Effects and Mechanisms of the Combination of Suberoylanilide Hydroxamic Acid and Bortezomib on the Anticancer Property of Gemcitabine in Pancreatic Cancer
- (2011) Jun Kyu Lee et al. PANCREAS
- The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines
- (2011) Andrea Morandi et al. PLoS One
- Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids
- (2010) Fredika M. Robertson et al. CANCER
- Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
- (2010) P. J. Grippo et al. Cancer Prevention Research
- Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
- (2010) K. T. Liby et al. Cancer Prevention Research
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
- (2010) Evette S. Radisky et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice
- (2009) K. Liby et al. Cancer Prevention Research
- Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
- (2009) A. Patsialou et al. CANCER RESEARCH
- Colony-Stimulating Factor-1 Receptor Inhibitors for the Treatment of Cancer and Inflammatory Disease
- (2009) Sharmila Patel et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
- (2008) Mayumi Ono CANCER SCIENCE
- Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
- (2008) K. Liby et al. CLINICAL CANCER RESEARCH
- Macrophages define the invasive microenvironment in breast cancer
- (2008) Jeffrey W. Pollard JOURNAL OF LEUKOCYTE BIOLOGY
- Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
- (2008) K. Almholt et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started